跳至主要内容
临床试验/NCT04948372
NCT04948372已完成不适用

Effects of Terlipressin Added to Usual Care vs. Usual Care Alone on Renal Perfusion in Patients With Septic Shock

Southeast University, China1 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2019年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
22
试验地点
1
主要终点
Peak intensity

研究概览

简要总结

This open-label, randomized controlled trial aimed to investigate the effect of a fixed dose of terlipressin added to usual care vs. usual care alone on renal perfusion in patients with septic shock.

详细描述

Terlipressin is a synthetic vasopressin analog with great affinity to the V1 receptor (vasoconstrictive effect), and could selectively contract efferent arterioles, increase glomerular filtration pressure and renal perfusion. The investigators conducted this open-label, randomized controlled trial to observe the effects of a fixed dose of terlipressin added to usual care vs. usual care alone on renal perfusion in patients with septic shock. Renal perfusion was monitored by renal contrast-enhanced ultrasound. The primary outcome was peak intensity (renal perfusion parameter) at 24 hours after enrollment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult septic shock patients (age≥18 years old)
  • Norepinephrine dose was more than or equal to 15μg/min

排除标准

  • Age older than 85 years
  • Serum creatinine more than 177 μmol/L
  • Acute myocardial ischemia
  • Acute mesenteric artery ischemia
  • Expected death within 24 hours.

研究组 & 干预措施

The usual care group

Placebo Comparator

Patients in the usual care group were treated with standard care.

干预措施: Usual care (Drug)

The terlipressin group

Experimental

Patients in the terlipressin group received a fixed dose of terlipressin added to usual care. Terlipressin was intravenously pumped at a fixed dose of 1.3μg/kg/hour for 24 hours.

干预措施: Terlipressin treatment (Drug)

结局指标

主要结局

Peak intensity

时间窗: 24 hours after enrollment

Peak intensity is the peak concentration of contrast agent, a kind of renal perfusion parameter monitored by renal contrast-enhanced ultrasound.

次要结局

  • The incidence of acute kidney injury(Within 28 days)
  • urine output, mL(24 hours after enrollment)

研究者

发起方
Southeast University, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jingyuan,Xu

Clinical Professor

Southeast University, China

研究点 (1)

Loading locations...

相似试验

Effects of Terlipressin on Renal Perfusion in... | 临床试验